Author

S. Sundaram

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:deep learning· 2 Research Focus:drug response / drug discovery· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1 Research Focus:clustering· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

A. C. I. van Steen· 1 shared A. Ladd· 1 shared A. M. Farell· 1 shared A. M. Lillo· 1 shared A. T. Zemla· 1 shared B. Dadonaite· 1 shared B. K. Petersen· 1 shared B. Rubinfeld· 1 shared

Activity by Year

2022-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

A. C. I. van Steen

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Three-dimensional modeling of flow through microvascular beds and surrounding interstitial spaces

N. K. Rajeeva Pandian, A. M. Farell, E. E. Davis, S. Sundaram, A. C. I. van Steen, J. L. C. Teo, J. Eyckmans, C. S. Chen

This paper develops a 3D computational model of microvascular beds and interstitial spaces to better understand fluid flow dynamics and the effects of vascular permeability.

Bioengineering & Translational Medicine · Nov 14, 2025Peer-reviewedBioengineering

Computationally restoring the potency of a clinical antibody against SARS-CoV-2 Omicron subvariants

T. A. Desautels, K. T. Arrildt, A. T. Zemla, E. Y. Lau, F. Zhu, D. Ricci, S. Cronin, S. Zost, E. Binshtein, S. M. Scheaffer, B. Dadonaite, B. K. Petersen, T. B. Engdahl, E. Chen, L. S. Handal, , Carnahan

This paper computationally redesigns an antibody to restore potency against SARS-CoV-2 Omicron subvariants while maintaining efficacy against Delta and other variants.

Nature · May 8, 2024Peer-reviewedMicrobiology

Augmented efficacy of uttroside B over sorafenib in a murine model of human hepatocellular carcinoma

M. Swetha, C. K. Keerthana, T. P. Rayginia, L. R. Nath, N. H. Haritha, K. Kalimuthu, S. Jannet, S. Pillai, K. B. Harikumar, S. Sundaram, N. P. Anto, D. H. Wu, R. S. Lankalapalli, R. Towner, N. Isakov, , R. J. Anto

This study compares the in vivo efficacy and safety of uttroside B and sorafenib in a murine model of hepatocellular carcinoma, finding Utt-B more potent and safer.

bioRxiv · Feb 1, 2022Cancer Biology